Last reviewed · How we verify
NCT02774083: Feuerstein
Cognitive Training Using Feuerstein Instrumental Enrichment
NA trial testing Feuerstein Program in Mild Cognitive Impairment in 26 participants. Completed in 31 May 2016.
31 May 2016
Quick facts
| Lead sponsor | Rambam Health Care Campus |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 26 |
| Start date | 3 September 2015 |
| Primary completion | 31 May 2016 |
| Estimated completion | 31 May 2016 |
| Sites | 5 locations across Israel |
Drugs / interventions tested
- Feuerstein Program
- Adler Program
Conditions studied
- Mild Cognitive Impairment — all drugs for Mild Cognitive Impairment →
Sponsor
Rambam Health Care Campus — full company profile →
Who can join
60 and older, any sex, with Mild Cognitive Impairment. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Background: The Feuerstein Instrumental Enrichment Program was designed to prevent mental deterioration and preserve cognitive abilities among people aged 60 and above. The program is an applied practicable program based on the theories of Structural Cognitive Modifiability as well as on a Mediated Learning Experience. The program takes into consideration the unique characteristics and requirements of the older population. The program is composed of a variety of cognitive tasks that offer systematic activities intended to stimulate mental and cognitive development. Objective: To examine the influence of the Feuerstein Program on the cognitive function and well-being of participants suffering from Mild Cognitive Impairment (MCI). Hypothesis: The Feuerstein Program will improve cognitive abilities and functional well-being of the participants. Methods: Residents of retirement homes will be offered to participate in the research. Participants will undergo cognitive and functional assessments that will be carried out on four specific dates. The participants of the Intervention Group will participate in the Feuerstein program using a method of mediated learning while the Control Group will participate in a program of the Adler Institute involving activities aimed at social and emotional development without specific cognitive skill training.
Publications & conference data
4 peer-reviewed publications reference this trial (live from Europe PMC):
-
Computerised cognitive training for preventing dementia in people with mild cognitive impairment.
Gates NJ, Vernooij RW, Di Nisio M, Karim S, et al · · 2019 · cited 97× · PMID 30864747 · DOI 10.1002/14651858.cd012279.pub2 -
Computerised cognitive training for 12 or more weeks for maintaining cognitive function in cognitively healthy people in late life.
Gates NJ, Rutjes AW, Di Nisio M, Karim S, et al · · 2020 · cited 53× · PMID 32104914 · DOI 10.1002/14651858.cd012277.pub3 -
Computerised cognitive training for maintaining cognitive function in cognitively healthy people in late life.
Gates NJ, Rutjes AW, Di Nisio M, Karim S, et al · · 2019 · cited 38× · PMID 30864187 · DOI 10.1002/14651858.cd012277.pub2 -
Computerised cognitive training for maintaining cognitive function in cognitively healthy people in midlife.
Gates NJ, Rutjes AW, Di Nisio M, Karim S, et al · · 2019 · cited 25× · PMID 30864746 · DOI 10.1002/14651858.cd012278.pub2
Verify or expand the search:
- PubMed search for NCT02774083
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Feuerstein Program
Trials testing the same drug.
- NCT03447236 — Functional MRI Changes Resulting From the Feuerstein Program in Older People With Mild Cognitive Impairment (MCI) · NA · completed
Other recruiting trials for Mild Cognitive Impairment
Currently open trials in the same condition.
- NCT05791994 — EVASION: Effect of VisuAl Stimulation on attentION · NA · recruiting
- NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
- NCT07220694 — Effects of Sabroxy® Supplementation on Insulin Resistance and Cognitive Function in Adults With Mild Cognitive Impairmen · NA · recruiting
- NCT06983769 — CPAP vs MAD for OSA in Patients With Cognitive Impairment. A Randomized Clinical Trial · NA · recruiting
- NCT07318038 — The Use of Rhythmic Light Therapy in Mild Cognitive Impairment · NA · recruiting
Other Rambam Health Care Campus trials
Trials by the same sponsor.
- NCT07384013 — Study Protocol: Impact of Metamizole (Optalgin®) on Anti-Xa Concentrations in Oncology Patients Receiving DOACs · NA · recruiting
- NCT06688253 — Intravenous Human IgG1 Fc Fragment (Efgartigimod) in Myasthenic Crisis · Phase 4 · not yet recruiting
- NCT06235749 — Administration Of Calcium Gluconate for The Reduction of Blood Loss During Elective Cesarean Delivery · NA · recruiting
- NCT06622902 — Influence of Flow Rate Change on CO2 Levels During High Flow Nasal Ventilation (HFNV) in Preterm Infants. · NA · recruiting
- NCT05922111 — Cervical Ripening Balloon for 12 Hours vs. 1 Hour. · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02774083 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Rambam Health Care Campus
- Last refreshed: 24 September 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02774083.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing